Literature DB >> 26478855

Resveratrol and Malignancies.

Rodica P Bunaciu1, Andrew Yen1.   

Abstract

Carcinogenesis is a multifactorial process, frequently encompassing 3 stages: initiation, promotion and progression. It is characterized by multiple deviations from normal both at the cell and organism levels. Although most people have a small number of cells that present deviations from normal, most of those cells will not cause cancer. However, some will. What tips the balance between normal and abnormal is the subject of intense scientific research as well as unfounded speculations. Chronic inflammation is one of the risk factors for cancer. Resveratrol is consumed by the population as a dietary supplement in the hope of decreasing the risk of inflammation and cancer and other chronic diseases such as diabetes and vascular diseases. There is a discrepancy between the doses used in the animal studies showing that resveratrol decreases all three stages of carcinogenesis, and the doses ingested by the population either as supplements or in the diet. While there is health benefit from using high resveratrol doses, it might be also of practical and scientific benefit to focus future effort in understanding the effects of normal dietary resveratrol levels.

Entities:  

Keywords:  3,4′,5-Trihydroxy-trans-stilbene; 5-[(1E)-2-(4-Hydroxyphenyl) ethenyl]-1,3-benzenediol; Resveratrol; Stilbene; cancer; human

Year:  2015        PMID: 26478855      PMCID: PMC4607076          DOI: 10.1007/s40495-015-0030-1

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  42 in total

Review 1.  The aryl hydrocarbon receptor: fine-tuning the immune-response.

Authors:  Marc Veldhoen; João H Duarte
Journal:  Curr Opin Immunol       Date:  2010-12       Impact factor: 7.486

2.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 3.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.

Authors:  Nikki B Marshall; Nancy I Kerkvliet
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.

Authors:  Catalina Lee-Chang; Monica Bodogai; Alejandro Martin-Montalvo; Katarzyna Wejksza; Mitesh Sanghvi; Ruin Moaddel; Rafael de Cabo; Arya Biragyn
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

5.  Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Authors:  Xiao-Min Yu; Renata Jaskula-Sztul; Kamal Ahmed; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Mol Cancer Ther       Date:  2013-04-17       Impact factor: 6.261

6.  Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.

Authors:  Wei Cheng; Yu Zhao; He Liu; Qin Fan; Fei-Fei Lu; Jing Li; Qin Yin; Chang-Dong Yan
Journal:  Fundam Clin Pharmacol       Date:  2014-08-15       Impact factor: 2.748

7.  Effects of stilbenes on arachidonate metabolism in leukocytes.

Authors:  Y Kimura; H Okuda; S Arichi
Journal:  Biochim Biophys Acta       Date:  1985-04-25

8.  Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.

Authors:  A Veronica Witte; Lucia Kerti; Daniel S Margulies; Agnes Flöel
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

Review 9.  AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.

Authors:  Eliza Vakana; Leonidas C Platanias
Journal:  Oncotarget       Date:  2011-12

Review 10.  The role of the aryl hydrocarbon receptor in normal and malignant B cell development.

Authors:  David H Sherr; Stefano Monti
Journal:  Semin Immunopathol       Date:  2013-08-13       Impact factor: 9.623

View more
  2 in total

Review 1.  Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy.

Authors:  Magdalena Jurczyk; Janusz Kasperczyk; Dorota Wrześniok; Artur Beberok; Katarzyna Jelonek
Journal:  Biomedicines       Date:  2022-05-20

2.  Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.

Authors:  Eva Dolezelova; Alena Prasnicka; Jolana Cermanova; Alejandro Carazo; Lucie Hyrsova; Milos Hroch; Jaroslav Mokry; Michaela Adamcova; Alena Mrkvicova; Petr Pavek; Stanislav Micuda
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.